Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Macrogenics (NQ: MGNX )

3.810 +0.040 (+1.06%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 14, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Macrogenics

< Previous 1 2
...
5 6 7 8 9 10 11 12 Next >
See Why Gilead's Cancer Business Is Driving The Stock To A Fever Pitch
Sales accelerated, again, in the third quarter. Here's what the company and analysts are watching. 
Via Investor's Business Daily
Where Macrogenics Stands With Analysts
Via Benzinga
Dow Jumps Over 300 Points; S&P 500 Rises 1%
U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining more than 300 points on Tuesday. 
Via Benzinga
Crude Oil Surges 2%; Best Buy Posts Upbeat Earnings
U.S. stocks traded higher midway through trading, with the Dow Jones gaining more than 250 points on Tuesday. 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Why Shares of MacroGenics Were Dropping Tuesday
Profit-taking and an analyst downgrade affected the stock's price. 
Via The Motley Fool
MacroGenics (MGNX) Q3 2022 Earnings Call Transcript
MGNX earnings call for the period ending September 30, 2022. 
Via The Motley Fool
Why Dollar Tree Shares Are Trading Lower By 10%? Here Are 53 Stocks Moving In Tuesday's Mid-Day Session
Gainers Palisade Bio, Inc. (NASDAQ: PALI) shares jumped 99.1% to $4.42 after the company announced the FDA granted Fast Track designation to LB1148 for the acceleration of time to return of bowel... 
Via Benzinga
US Stocks Open Higher As Dow Surges 250 Points
U.S. stocks traded higher this morning, with the Dow Jones gaining around 250 points on Tuesday. 
Via Benzinga
First Drug That Can Delay Onset of Type 1 Diabetes Gets FDA Approval After Multiple Regulatory Hurdles
Via Benzinga
Gap, Palo Alto Networks And Some Other Big Stocks Moving Higher In Today's Pre-Market Session
U.S. stock futures traded higher this morning. Here are some big stocks recording gains in today’s pre-market trading session. 
Via Benzinga
MacroGenics Earns $60 Million Milestone with U.S. FDA Approval of Teplizumab
From MacroGenics, Inc.
Via GlobeNewswire
Why MacroGenics Stock Crushed the Market on Monday
Positive momentum continues for the cancer specialist in the wake of its latest earnings report. 
Via The Motley Fool
MacroGenics To Surge 138%? Plus This Analyst Sees $50 For Exact Sciences
BMO Capital boosted the price target on MacroGenics, Inc. (NASDAQ: MGNX) from $5.7 to $16. BMO Capital analyst Etzer Darout upgraded the stock from Market Perform to Outperform. MacroGenics shares... 
Via Benzinga
360 DigiTech, HUTCHMED And Some Other Big Stocks Moving Higher In Today's Pre-Market Session
U.S. stock futures traded lower this morning. Here are some big stocks recording gains in today’s pre-market trading session. 
Via Benzinga
Blue Star (NASDAQ: BSFC) Insiders Are Buying Stock
One indicator of where a company’s stock might be going in the future can be understood by what insiders may be thinking of the Company’s current stock price and near-term future outlook. Insiders are... 
Via Benzinga
Why MacroGenics Stock Popped Again Today
Investors and analysts alike are getting more bullish on the company in the wake of its third-quarter results. 
Via The Motley Fool
Why MacroGenics Stock Blasted Higher Today
A quarter that was far better than expected gets investors excited about the biotech at the end of the week. 
Via The Motley Fool
12 Health Care Stocks Moving In Friday's Intraday Session
Gainers 
Via Benzinga
Why MediaAlpha Shares Jumped Around 30%; Here Are 112 Biggest Movers From Friday
Gainers 
Via Benzinga
Why Yelp Shares Are Trading Lower By 15%? Here Are 86 Stocks Moving In Friday's Mid-Day Session
Gainers 
Via Benzinga
MacroGenics to Participate in Upcoming Investor Conferences
From MacroGenics, Inc.
Via GlobeNewswire
Provention Bio's Second Try, Apellis's Eye Disorder Drug Review, 3 Adcom Verdicts And More: November's Key PDUFA Catalysts Biotech Investors Must Know
October proved to be a mixed month for the Food and Drug Administration’s regulatory decisions. Two new molecular entities, or NMEs, were approved during the month, bringing the tally for the... 
Via Benzinga
MacroGenics Announces Date of Third Quarter 2022 Financial Results Conference Call
From MacroGenics, Inc.
Via GlobeNewswire
$7.5 Million Bet On Local Bounti? Check Out These 3 Penny Stocks Insiders Are Buying
US crude oil futures traded higher this morning on Wednesday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or... 
Via Benzinga
$1.8 Million Bet On MacroGenics? Check Out These 3 Penny Stocks Insiders Are Buying
The Dow Jones traded higher by over 400 points on Monday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern... 
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Gainers 
Via Benzinga
Analyst Ratings for Macrogenics
Over the past 3 months, 5 analysts have published their opinion on Macrogenics (NASDAQ:MGNX) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a... 
Via Benzinga
MacroGenics Shares Jump On Gilead Licensing Pact For Blood Cancer Candidates
Via Benzinga
Why Huntington Bancshares Shares Surged Around 10%; Here Are 72 Biggest Movers From Friday
Gainers Huadi International Group Co., Ltd. (NASDAQ: HUDI) jumped 89.3% to close at $58.92 on Friday. 
Via Benzinga
< Previous 1 2
...
5 6 7 8 9 10 11 12 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.